Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Daprodustat in ESRD on Peritoneal Dialysis
NCT02243306Phase 1Completed
- Sponsor
- GSK
- Start
- Oct 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of daprodustat in anemia of chronic kidney disease (CKD-A) (2 cohorts), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve Over the Dosing Interval at Day 14, Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time at Day 1 and 1 more. Started Oct 2014; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02243306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243306.